A role for endogenous peptide YY in tachykinin NK2 receptor-triggered 5-HT release from guinea pig isolated colonic mucosa

British Journal of Pharmacology

Volumn 167, Issue 6, 2012, Pages 1362-1368

  Kojima, Shu Ichi ^a   Tohei, Atsushi ^a   Anzai, Naohiko ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

5 HT release; colon; NK2 receptors; peptide YY; serotonin release; tachykinin

Indexed keywords

BIB03304; N [2 [1,2 DIHYDRO 3,5(4H) DIOXO 1,2 DIPHENYL 1,2,4 TRIAZOL 4 YL]ETHYL] N2 [[1 [2 [4 [5,11 DIHYDRO 6(6H) OXODIBENZ[B,E]AZEPIN 11 YL] 1 PIPERAZINYL] 2 OXOETHYL]CYCLOPENTYL]ACETYL]ARGININAMIDE; N2 DIPHENYLACETYL N (4 UREIDOMETHYLBENZYL)ARGININAMIDE; PEPTIDE YY; SEROTONIN; TACHYKININ; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLON MUCOSA; DRUG POTENCY; ELECTROCHEMICAL DETECTION; ENZYME IMMUNOASSAY; GUINEA PIG; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; INCUBATION TIME; NONHUMAN; PRIORITY JOURNAL; SEROTONIN RELEASE;

ANIMALS; COLON; GUINEA PIGS; INTESTINAL MUCOSA; MALE; NEUROKININ A; PEPTIDE FRAGMENTS; PEPTIDE YY; RECEPTORS, NEUROKININ-2; SEROTONIN;

EID: 84867798614     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.02094.x     Document Type: Article

References (33)

1. Adrian TE, Ferri GL, Bacarese- Hamilton AJ, Fuessl HS, Polak JM, Bloom SR, (1985). Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 89: 1070-1077.
2. Alexander SPH, Mathie A, Peters JA, (2011). Guide to receptors and channels, 5th edn. Br J Pharmacol 164 (Suppl. 1): S85.
3. Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, Frost GS, et al,. (2003). Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 349: 941-948.
4. Bearcroft CP, Perrett D, Farthing MJG, (1998). Postprandial plasma 5-hydroxytryptamine in diarrhea predominant irritable bowel syndrome: a pilot study. Gut 42: 42-46.
5. Camilleri M, (2002). Serotonergic modulation of visceral sensation: lower gut. Gut 51 (Suppl. 1): i81-i86.
6. Coates MD, Mahoney CR, Linden DR, Sampson JE, Chen J, Blaszyk H, et al,. (2004). Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 126: 1657-1664.
7. Costedio MM, Hyman N, Mawe GM, (2007). Serotonin and its role in colonic function and in gastrointestinal disorders. Dis Colon Rectum 50: 376-388.
8. 4 receptors mediate Y agonist responses in isolated human colon mucosa. Br J Pharmacol 135: 1505-1512.
9. Cremon C, Carini G, Wang B, Vasina V, Cogliandro RF, De Giorgio R, et al,. (2011). Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome. Am J Gastroenterol 106: 1290-1298.
10. Ferrier L, Segain JP, Pacaud P, Cherbut C, Loirand G, Galmiche JP, et al,. (2000). Pathways and receptors involved in peptide YY induced contraction of rat proximal colonic muscle in vitro. Gut 46: 370-375.
11. Gershon MD, Tack J, (2007). The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 132: 397-414.
12. Holzer P, (1998). Implications of tachykinins and calcitonin gene-related peptide in inflammatory bowel disease. Digestion 59: 269-283.
13. Houghton LA, Atkinson W, Whitaker RP, Whorwell PJ, Rimmer MJ, (2003). Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhea predominant irritable bowel syndrome. Gut 52: 663-670.
14. Karra E, Batterham RL, (2010). The role of gut hormones in the regulation of body weight and energy homeostasis. Mol Cell Endocrinol 316: 120-128.
15. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). NC3Rs Reporting Guidelines Working Group. Br J Pharmacol 160: 1577-1579.
16. 3 receptors. Br J Pharmacol 141: 385-390.
17. 2-receptor-triggered serotonin release from guinea-pig colonic mucosa. J Pharmacol Sci 98: 175-180.
18. 2 receptor-triggered serotonin release from guinea-pig proximal colon. J Pharmacol Sci 110: 122-126.
19. 2 receptor- triggered 5-HT release from guinea-pig isolated colonic mucosa. Br J Pharmacol 162: 1179-1185.
20. Lecci A, Capriati A, Maggi CA, (2004). Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome. Br J Pharmacol 141: 1249-1263.
21. Maier C, Riedl M, Vila G, Nowotny P, Wolzt M, Clodi M, et al,. (2008). Cholinergic regulation of ghrelin and peptide YY release may be impaired in obesity. Diabetes 57: 2332-2340.
22. McGrath J, Drummond G, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
23. Miwa J, Echizen H, Matsueda K, Umeda N, (2001). Patients with constipation-predominant irritable bowel syndrome. Digestion 63: 188-194.
24. Neary MT, Batterham RL, (2009). Peptide YY: food for thought. Physiol Behav 97: 616-619.
25. Onaga T, Zabielski R, Kato S, (2002). Multiple regulation of peptide YY secretion in the digestive tract. Peptides 23: 279-290.
26. Plaisancie P, Bernard C, Chayvialle JA, Cuber JC, (1995). Release of peptide YY by neurotransmitters and gut hormones in the isolated, vascularly perfused rat colon. Scand J Gastroenterol 30: 568-574.
27. Portbury AL, Furness JB, Southwell BR, Wong H, Walsh JH, Bunnett NW, (1996). Distribution of neurokinin-2 receptors in the guinea-pig gastrointestinal tract. Cell Tissue Res 286: 281-292.
28. Racke K, Schworer H, (1991). Regulation of serotonin release from the intestinal mucosa. Pharmacol Res 23: 13-25.
29. Sawa T, Mameya S, Yoshimura M, Itsuno M, Makiyama K, Niwa M, et al,. (1995). Differential mechanism of peptide YY and neuropeptide Y in inhibiting motility of guinea-pig colon. Eur J Pharmacol 276: 223-230.
30. Simren M, Stotzer PO, Sjovall H, Abrahamsson H, Bjornsson ES, (2003). Abnormal levels of neuropeptide Y and peptide YY in the colon in irritable bowel syndrome. Eur J Gastroenterol Hepatol 15: 55-62.
31. Spiller RC, Jenkins D, Thornley JP, Hebden JM, Wright T, Skinner M, et al,. (2000). Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acte Campylobacter enteritis and in post-dysenteric irritable bowel sundorome. Gut 47: 804-811.
32. 2 receptors. Br J Pharmacol 164: 471-484.
33. 1 receptor antagonist BIBO3304 and its effect on feeding in rodents. Br J Pharmacol 125: 549-555.